Middle East & Africa Blood Plasma Derivatives Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Middle East & Africa Blood Plasma Derivatives Market – by Type

1.3.2 Middle East & Africa Blood Plasma Derivatives Market – by Application

1.3.3 Middle East & Africa Blood Plasma Derivatives Market – by End User

1.3.4 Middle East & Africa Blood Plasma Derivatives Market – by Country

2. Middle East & Africa Blood Plasma Derivatives Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Blood Plasma Derivatives Market – Market Landscape

4.1 Overview

4.2 Middle East & Africa PEST Analysis

4.3 Expert’s Opinion

5. Middle East & Africa Blood Plasma Derivatives Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Blood Disorders

5.1.2 Rise in Geriatric Population

5.2 Market Restraints

5.2.1 Complicated Reimbursement Policies

5.3 Market Opportunities

5.3.1 Incorporation of Platelet-Rich Plasma in Regenerative Medicine

5.4 Future Trends

5.4.1 Increasing Usage of Immunoglobulin G in Multiple Treatments

5.5 Impact Analysis

6. Blood Plasma Derivatives Market – Middle East & Africa Analysis

6.1 Middle East & Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7. Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – by Type

7.1 Overview

7.2 Middle East & Africa Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)

7.3 Albumin

7.3.1 Overview

7.3.2 Albumin: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Factor VIII

7.4.1 Overview

7.4.2 Factor VIII: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Factor IX

7.5.1 Overview

7.5.2 Factor IX: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Immunoglobulin

7.6.1 Overview

7.6.2 Immunoglobulin: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.3 IgG

7.6.3.1 Overview

7.6.3.2 IgG: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.4 IgM

7.6.4.1 Overview

7.6.4.2 IgM: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.5 IgA

7.6.5.1 Overview

7.6.5.2 IgA: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.6 IgD

7.6.6.1 Overview

7.6.6.2 IgD: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.6.7 IgE

7.6.7.1 Overview

7.6.7.2 IgE: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Hyperimmune Globulin

7.7.1 Overview

7.7.2 Hyperimmune Globulin: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

7.8 Others

7.8.1 Overview

7.8.2 Others: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8. Middle East & Africa Blood Plasma Derivatives Market Analysis and Forecasts to 2028 – by Application

8.1 Overview

8.2 Middle East & Africa Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)

8.3 Hemophilia

8.3.1 Overview

8.3.2 Hemophilia: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Hypogammaglobulinemia

8.4.1 Overview

8.4.2 Hypogammaglobulinemia: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Immunodeficiency Diseases

8.5.1 Overview

8.5.2 Immunodeficiency Diseases: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Von Willebrand Disease

8.6.1 Overview

8.6.2 Von Willebrand Disease: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Other Applications

8.7.1 Overview

8.7.2 Other Applications: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – by End User

9.1 Overview

9.2 Middle East & Africa Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Clinics

9.4.1 Overview

9.4.2 Clinics: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Other End Users

9.5.1 Overview

9.5.2 Other End Users: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10. Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 – Country Analysis

10.1 Overview

10.1.1.1 UAE: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 UAE: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 UAE: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.1.3.1 UAE: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.1.4 UAE: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.1.5 UAE Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.2 Saudi Arabia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 Saudi Arabia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3 Saudi Arabia: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.2.3.1 Saudi Arabia: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.2.4 Saudi Arabia: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.2.5 Saudi Arabia Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.3 South Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 South Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3 South Africa: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.3.3.1 South Africa: Blood Plasma Derivatives Market, by Immunoglobulin, 2019–2028 (US$ Million)

10.1.1.3.4 South Africa: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.3.5 South Africa Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

10.1.1.4 Rest of Middle East & Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 Rest of Middle East & Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3 Rest of Middle East & Africa: Blood Plasma Derivatives Market, by Type, 2019–2028 (US$ Million)

10.1.1.4.3.1 Rest of Middle East: Blood Plasma Derivatives Market, by immunoglobulin, 2019–2028 (US$ Million)

10.1.1.4.4 Rest of Middle East & Africa: Blood Plasma Derivatives Market, by Application, 2019–2028 (US$ Million)

10.1.1.4.5 Rest of Middle East & Africa Blood Plasma Derivatives Market, by End User, 2019–2028 (US$ Million)

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Blood Plasma Derivatives Market

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Grifols SA

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 SK Plasma Co Ltd

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Octapharma AG

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Monobind Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Intas Pharmaceuticals Ltd

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Fusion Health Care Pvt Ltd

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 CSL Behring LLC

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 LFB SA

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Kedrion SpA

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. UAE Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 2. UAE Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 3. UAE Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 4. UAE Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 5. Saudi Arabia Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 6. Saudi Arabia Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 7. Saudi Arabia Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 8. Saudi Arabia Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 9. South Africa Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 10. South Africa Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 11. South Africa Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 12. South Africa Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13. Rest of Middle East & Africa Blood Plasma Derivatives Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 14. Rest of Middle East Plasma Derivatives Market, by Immunoglobulin – Revenue and Forecast to 2028 (US$ Million)

Table 15. Rest of Middle East & Africa Blood Plasma Derivatives Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 16. Rest of Middle East & Africa Blood Plasma Derivatives Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17. Recent Inorganic Growth Strategies in the Blood Plasma Derivatives Market

Table 18. Recent Organic Growth Strategies in the Blood Plasma Derivatives Market

Table 19. Glossary of Terms

LIST OF FIGURES

Figure 1. Middle East & Africa Blood Plasma Derivatives Market Segmentation

Figure 2. Middle East & Africa Blood Plasma Derivatives Market, by Country

Figure 3. Middle East & Africa Blood Plasma Derivatives Market Overview

Figure 4. Immunoglobulin Segment Held Largest Share of Type Segment in Middle East & Africa Blood Plasma Derivatives Market

Figure 5. UAE is Expected to Show Remarkable Growth During Forecast Period

Figure 6. Middle East & Africa: PEST Analysis

Figure 7. Experts’ Opinion

Figure 8. Middle East & Africa Blood Plasma Derivatives Market: Impact Analysis of Drivers and Restraints

Figure 9. Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. Middle East & Africa Blood Plasma Derivatives Market Revenue Share, by Type 2021 & 2028 (%)

Figure 11. Albumin: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Factor VIII: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Factor IX: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Immunoglobulin: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. IgG: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. IgM: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. IgA: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. IgD: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. IgE: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Hyperimmune Globulin: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Others: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. Middle East & Africa Blood Plasma Derivatives Market, by Application 2021 & 2028 (%)

Figure 23. Hemophilia: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. Hypogammaglobulinemia: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. Immunodeficiency Diseases: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. Von Willebrand Disease: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. Other Applications: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. Middle East & Africa Blood Plasma Derivatives Market Revenue Share, by End User 2021 & 2028 (%)

Figure 29. Hospitals: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Clinics: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Other End Users: Middle East & Africa Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. Middle East & Africa: Blood Plasma Derivatives Market, by Key Country – Revenue (2021) (US$ Million)

Figure 33. Middle East & Africa: Blood Plasma Derivatives Market, by Country, 2021 & 2028 (%)

Figure 34. UAE: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Saudi Arabia: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. South Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37. Rest of Middle East & Africa: Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38. Growth Strategies in the Blood Plasma Derivatives Market